Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
The effects of relaxin may be beneficial in the treatment of women with preeclampsia. This study will preliminarily evaluate the maternal, fetal and neonatal safety and tolerability of an IV infusion of relaxin compared with placebo given to women with severe preeclampsia.
Age
18–40
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of preeclampsia
Hospital admission for expectant management
You may not be if
Eclampsia or history of seizures
Vaginal bleeding
Multifetal gestation
Requirement for immediate delivery
Clareo Health | Evaluation of the Safety of Relaxin in Preeclampsia
